Product Recalls in Ohio

Product recalls affecting Ohio — including food, drugs, consumer products, medical devices, and vehicles distributed to Ohio. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,779 recalls have been distributed to Ohio in the last 12 months.

55,415 total recalls
2,779 in last 12 months

Showing 60616080 of 13,469 recalls

DrugMarch 1, 2019· American Health Packaging

Recalled Item: Aspirin and Extended-release Dipyridamole Capsules Recalled by American...

The Issue: Failed Impurities/Degradation Specifications; out of specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Camber Pharmaceuticals Inc

Recalled Item: Losartan Potassium Tablets USP Recalled by Camber Pharmaceuticals Inc Due to...

The Issue: CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Camber Pharmaceuticals Inc

Recalled Item: Losartan Potassium Tablets USP Recalled by Camber Pharmaceuticals Inc Due to...

The Issue: CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Camber Pharmaceuticals Inc

Recalled Item: Losartan Potassium Tablets USP Recalled by Camber Pharmaceuticals Inc Due to...

The Issue: CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: Losartan Potassium / Hydrochlorothiazide Tablets Recalled by Torrent Pharma...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: Losartan Potassium / Hydrochlorothiazide Tablets Recalled by Torrent Pharma...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: Losartan Potassium / Hydrochlorothiazide Tablets Recalled by Torrent Pharma...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 26, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Moxifloxacin Ophthalmic Solution USP Recalled by Lupin Pharmaceuticals Inc....

The Issue: Failed Impurities/Degradation Specifications: Expansion of July 2018 and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 25, 2019· Macleods Pharma Usa Inc

Recalled Item: Telmisartan and Hyrdochlorothiazide Tablets 40mg/12.5 mg Recalled by...

The Issue: Failed Content Uniformity Specifications: The product is out of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 25, 2019· Macleods Pharma Usa Inc

Recalled Item: Telmisartan and Hyrdochlorothiazide Tablets Recalled by Macleods Pharma Usa...

The Issue: Failed Content Uniformity Specifications: The product is out of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 25, 2019· Macleods Pharma Usa Inc

Recalled Item: Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mg Recalled by Macleods...

The Issue: Failed Content Uniformity Specifications: The product is out of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 22, 2019· Akorn, Inc.

Recalled Item: Gentamicin Sulfate Ophthalmic Solution Recalled by Akorn, Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: High Out-of-Specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 22, 2019· Golean Detox US

Recalled Item: Golean DETOX capsules Recalled by Golean Detox US Due to Undeclared Sibutramine

The Issue: Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 22, 2019· Ascend Laboratories LLC

Recalled Item: Tamsulosin Hydrochloride Capsules Recalled by Ascend Laboratories LLC Due to...

The Issue: Failed Dissolution Specifications: High Out-of-Specification dissolution...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 21, 2019· Lannett Company Inc.

Recalled Item: Oxybutynin Chloride Recalled by Lannett Company Inc. Due to Failed...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 19, 2019· American Health Packaging

Recalled Item: Lovastatin Tablets USP Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Finished product made with lovastatin drug substance that...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 15, 2019· Heritage Pharmaceuticals, Inc.

Recalled Item: Etomidate Injection Recalled by Heritage Pharmaceuticals, Inc. Due to...

The Issue: Subpotent Drug.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund